Editas Medicine Inc (EDIT)

Editas Medicine (EDIT) Financial Statements


Editas Medicine Financial Overview

Editas Medicine's market cap is currently ―. The company's EPS TTM is $-2.102; its P/E ratio is -2.86; Editas Medicine is scheduled to report earnings on July 31, 2024, and the estimated EPS forecast is $-0.70. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 5.34M$ 2.89M$ 9.85M$ 6.54M$ 42.00K
Gross Profit$ 5.34M$ 2.89M$ 9.85M--
EBIT$ -45.02M$ -40.29M$ -49.04M$ -63.45M$ -57.52M
EBITDA$ -46.23M$ -38.75M$ -47.49M$ -61.87M$ -55.92M
Net Income Common Stockholders$ -45.02M$ -40.29M$ -49.04M$ -60.74M$ -55.73M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 349.62M$ 431.97M$ 318.44M$ 344.27M$ 419.62M
Total Assets$ 504.65M$ 541.95M$ 464.11M$ 514.32M$ 531.03M
Total Debt$ 34.61M$ 37.19M$ 37.14M$ 43.95M$ 21.30M
Net Debt$ -315.01M$ -394.78M$ -281.30M$ -300.33M$ -398.32M
Total Liabilities$ 144.19M$ 142.04M$ 146.63M$ 153.64M$ 116.28M
Stockholders Equity$ 360.46M$ 399.92M$ 317.47M$ 360.68M$ 414.75M
Cash Flow-
Free Cash Flow$ -35.70M$ -40.04M$ -37.61M$ -42.90M$ -48.62M
Operating Cash Flow$ -35.46M$ -38.71M$ -35.77M$ -42.27M$ -48.00M
Investing Cash Flow$ -102.82M$ 12.98M$ 23.27M$ -27.53M$ 89.23M
Financing Cash Flow-$ 117.53M-$ 619.00K$ 80.00K
Currency in USD

Editas Medicine Earnings and Revenue History

Editas Medicine Debt to Assets

Editas Medicine Cash Flow

Editas Medicine Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis